Peifer Christian, Urich Robert, Schattel Verena, Abadleh Mohammed, Röttig Marc, Kohlbacher Oliver, Laufer Stefan
Department of Pharmacy, Eberhard-Karls-University, Auf derMorgenstelle 8B, D-72076 Tübingen, Germany.
Bioorg Med Chem Lett. 2008 Feb 15;18(4):1431-5. doi: 10.1016/j.bmcl.2007.12.073. Epub 2008 Jan 5.
In this study we report on the specificity profiling of the MAP kinase inhibitors 1, 2, and 3 in a panel of 78 protein kinases including the MAPK isoforms p38(alpha,beta,gamma,delta), JNK1/2/3, and ERK1/2/8 showing 3-(4-fluorophenyl)-4-pyridin-4-ylquinolin-2(1H)-one (1) to be highly selective for p38alphaMAPK with an IC(50) of 1.8 microM. In contrast, besides p38alpha the isoxazoles 2 and 3 significantly inhibited JNK2/3 and further kinases beyond the MAPK family such as PKA, PKD, Lck, and CK1. By using sequence alignment and homology models of different members of the MAPK family the binding mode determining selectivity of 1 for the p38alpha isoform was investigated. For lead optimization of 1 a straightforward tandem-Buchwald-aldol synthetic approach toward the flexible decoration of the quinolin-2(1H)-one scaffold was employed. SAR for derivatives of 1 at the isolated p38alphaMAPK are presented.
在本研究中,我们报告了丝裂原活化蛋白激酶(MAPK)抑制剂1、2和3在一组78种蛋白激酶中的特异性概况,这组蛋白激酶包括MAPK亚型p38(α、β、γ、δ)、JNK1/2/3和ERK1/2/8,结果表明3-(4-氟苯基)-4-吡啶-4-基喹啉-2(1H)-酮(1)对p38α MAPK具有高度选择性,IC50为1.8 μM。相比之下,除了p38α外,异恶唑2和3还显著抑制JNK2/3以及MAPK家族以外的其他激酶,如蛋白激酶A(PKA)、蛋白激酶D(PKD)、淋巴细胞特异性蛋白酪氨酸激酶(Lck)和酪蛋白激酶1(CK1)。通过使用MAPK家族不同成员的序列比对和同源模型,研究了决定1对p38α亚型选择性的结合模式。为了对1进行先导化合物优化,采用了一种直接的串联布赫瓦尔德-羟醛合成方法,对喹啉-2(1H)-酮支架进行灵活修饰。本文介绍了1的衍生物在分离出的p38α MAPK上的构效关系。